PTEN splice site variants
About
Gene context: PTEN
Biomarker Type: Somatic Variant
Present: True
Chromosome: 10
Variant Annotation: Splice Site
Requires Oncogenic: True
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | ER positive, HER2-negative, PTEN splice site variants | Invasive Breast Carcinoma | Capivasertib, Fulvestrant | |
| FDA (1) | HER2-negative, PR positive, PTEN splice site variants | Invasive Breast Carcinoma | Capivasertib, Fulvestrant | |
| FDA (1) | ER positive, HER2-negative, PR positive, PTEN splice site variants | Invasive Breast Carcinoma | Capivasertib, Fulvestrant |